Pharmocann Global Ltd Share Price TEL AVIV STOCK EXCHANGE
Equities
PMCN
IL0010968902
Healthcare Facilities & Services
Sales 2022 | 22.66M 6.04M 504M | Sales 2023 | 14.41M 3.84M 321M | Capitalization | 3.12M 833K 69.46M |
---|---|---|---|---|---|
Net income 2022 | -25M -6.67M -556M | Net income 2023 | -9M -2.4M -200M | EV / Sales 2022 | 0.4 x |
Net cash position 2022 | 925K 247K 20.58M | Net cash position 2023 | 768K 205K 17.09M | EV / Sales 2023 | 0.16 x |
P/E ratio 2022 |
-0.26
x | P/E ratio 2023 |
-0.28
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 51.05% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 40 | 17/19/17 | |
Daniel Spira
AUD | Comptroller/Controller/Auditor | 69 | 29/19/29 |
Members of the board | Title | Age | Since |
---|---|---|---|
Guy Sigura
CHM | Chairman | 47 | 05/22/05 |
Locar Gila
BRD | Director/Board Member | 51 | 29/22/29 |
Director/Board Member | 43 | 29/22/29 |
1st Jan change | Capi. | |
---|---|---|
+29.90% | 272M | |
+44.86% | 261M | |
+50.00% | 194M | |
+43.48% | 131M | |
-28.57% | 121M | |
+115.91% | 119M | |
-36.75% | 119M | |
0.00% | 86.82M | |
+150.00% | 75.33M |